The Asia Pacificbrain aneurysm treatment market is expected to reach US$1,737.32millionby 2027from US$ 576.71millionin 2019. The market is estimated to grow at a CAGR of 14.9%from 2020 to 2027.
The growth of the market is attributed torise in research activities, increasing prevalence of brain aneurysm, and growingnumber of product launches. However, the high cost of procedureshinders the growth of the market in Asia Pacific.
The Asia Pacific brain aneurysm treatment market is expected to witness significant growth during the forecast period due to growingprevalence of associated risk factors such as hypertension and brain strokes. Also, players in the regional market might find growth opportunities with the rising number of market approvalsfor their products.For instance, in December 2019, Kaneka Corporation launched a new coil for embolization of brain aneurysm. The product is expected to offer more treatment options in geriatric population and patients with high blood pressure and other chronic conditions.
China is among the major countries in the brain aneurysm treatment market in this region. The growth of China brain aneurysm treatment market is prominently attributed to a rising prevalence of stroke and increasing research and development programs to innovate new treatment alternatives. As per the study published in the National Center for Biotechnology Information, the prevalence of unruptured intracranial aneurysm (UIA) is as high as 7% among 35–75-year-old individuals in China.
Additionally, rapid technological innovations and collaborations are boosting the brain aneurysm treatment market growth in the country. For instance, in 2019, LPIXEL Inc., a prominent leader in image analysis and processing, received an approval for EIRL aneurysm fromPharmaceuticals and Medical Devices Agency (PMDA) in Japan. The product is a deep learning-powered software thatcanbe used in identifying suspected aneurysms from brain MRI.
Asia Pacific Brain Aneurysm Treatment Market Revenue and Forecast to 2027 (US$ Million)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Asia PacificBrain Aneurysm Treatment Market Segmentation
By Type
- Surgery
- Medication
By Condition
- Unruptured Aneurysm
- Ruptured Aneurysm
By End User
- Hospitals
- Clinics
By Country
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
Company Profiles
- Stryker Corporation
- MicroPort Scientific Corporation
- Terumo Corporation
- KANEKA CORPORATION
- Mizuho Medical Co,Ltd.
Asia Pacific Brain Aneurysm Treatment Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 576.71 Million |
| Market Size by 2027 | US$ 1,737.32 Million |
| Global CAGR (2020 - 2027) | 14.9% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | Asia-Pacific
|
| Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Transdermal Drug Delivery System Market
- Ceiling Fans Market
- Underwater Connector Market
- Dried Blueberry Market
- Vision Guided Robotics Software Market
- Industrial Inkjet Printers Market
- Bathroom Vanities Market
- Workwear Market
- Trade Promotion Management Software Market
- Batter and Breader Premixes Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Condition, End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Asia Pacific Brain Aneurysm Treatment Market
- Stryker Corporation
- MicroPort Scientific Corporation
- Terumo Corporation
- KANEKA CORPORATION
- Mizuho Medical Co,Ltd.
Get Free Sample For